Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of the QUITOXIL® System on Smoking Cessation in Patients With Tobacco Use Disorder : a Randomized Controlled Clinical Trial.

NCT07722832 is registered in ClinicalTrials.gov with KLAVA Innovation as lead sponsor.

NCT NCT07722832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07722832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of the QUITOXIL® System on Smoking Cessation in Patients With Tobacco Use Disorder : a Randomized Controlled Clinical Trial.
Lead sponsor
KLAVA Innovation
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2028
Enrollment
606 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco use disorder